Latest Contrast Nephropathy News
In a study, the odds of acute kidney injury were 7% lower among patients who received radiocontrast versus those who did not.
CIN developed in 14.7% of patients with low hemoglobin levels compared with 5% of those with normal levels.
N-acetylcysteine patients had significantly decreased odds of contrast-induced nephropathy.
CARIN trial reported no significant differences in acute kidney injury incidence between novel compound CMX-2043 and placebo.
Greatest reduction for N-acetylcysteine in patients receiving low-osmolar contrast media.
Risk is linked to small changes in serum creatinine and eGFR on the day after contrast exposure.
Reduced risk of contrast-induced nephropathy with no increase in acute heart failure.
Study reveals a 13% incidence of CIN in allograft recipients undergoing computed tomography or cardiac catheterization with contrast media.
Contrast-Induced Nephropathy is significantly associated with mortality and need for dialysis; hydration is also a predictor of CIN.
Increased long-term mortality risk for patients with, but not those without, chronic kidney disease.
Researchers found no statistically significant incidence of CIN in a study of 2,277 patients who had a total of 2,583 CT scans with contrast.
In a study of patients undergoing coronary procedures, the incidence of CIN was 2.7% alprostadl recipients versus 11.1% of controls.
The condition was 67% less likely to develop in patients who received a nitrate before percutaneous coronary intervention.
It might decrease the likelihood of renal function decline, however.
Contrast volume:eGFR ratio may be useful in calculating the maximum amount of contrast to give.
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)